Head and neck osteosarcoma in adults: The province of alberta experience over 26 years

Journal of Otolaryngology - Head and Neck Surgery

Volumn 37, Issue 5, 2008, Pages 738-743

  Huber, Gerhard F ^a   Dziegielewski, Peter ^b   Matthews, T Wayne ^c   Dort, Joseph C ^c  

^a Head and Neck Surgery ^*  (Switzerland)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Head and neck; Osteosarcoma; Outcome

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; OSTEOSARCOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALBERTA; CAUSE OF DEATH; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 64349087252     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2008.OA0169     Document Type: Article

References (22)

1. Goepfert H, Raymond K, Spires JR. Osteosarcoma of the head and neck. Cancer Bull 1990;42:347-54.
2. Unni KK, Dahlin DC. Osteosarcoma: pathology and classification. Semin Roentgenol 1989;24:143-52.
3. Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003;97:3068-75.
4. Patel SG, Meyers P, Huvos AG, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 2002;95:1495-503.
5. Smith RB, Apostolakis LW, Karnell LH, et al. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003;98:1670-80.
6. Daw NC, Mahmoud HH, Meyer WH, et al. Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience. Cancer 2000;88:2172-80.
7. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. Springer. New York, Berlin, Heidelberg. 2002.
8. Cahan WG, Woodard HQ, Higginbotham NL, et al. Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer 1998;82:8-34.
9. Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol 2004;33:139-44.
10. Mark RJ, Sercarz JA, Tran L, et al. Osteogenic sarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg 1991;117:761-6.
11. Oda D, Bavisotto LM, Schmidt RA, et al. Head and neck osteosarcoma at the University of Washington. Head Neck 1997; 19:513-23.
12. Bertoni F, Dallera P, Bacchini P, et al. The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer 1991;68: 1555-63.
13. Kassir RR, Rassekh CH, Kinsella JB, et al. Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope 1997;107:56-61.
14. WhelanJ,SeddonB,PerisoglouM.Managementofosteosarcoma. Curr Treat Options Oncol 2006;7:44-55.
15. Harting MT, Blakely ML. Semin Pediatr Surg 2006;15:25-9.
16. DeLaney TF, Park L, Goldberg SI, et al. Radiotherapy for local control ofosteosarcoma. Int J Radiat Oncol Biol Phys 2005;61:492-8.
17. Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival ofcraniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 1997;15:363-7.
18. Sturgis EM, Potter BO. Sarcomas of the head and neck region. Curr Opin Oncol 2003;15:239-52.
19. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-90.
20. Jaffe N, Patel SR, Benjamin RS. Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation. Hematol Oncol Clin North Am 1995;9:825-40.
21. Ganjavi H, Gee M, Narendran A, et al. Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin. Cancer Gene Ther 2005;12:397-406.
22. Steinert DM, Blakely LJ, Salganick J, Trent JC. Molecular targets in therapy for human soft-tissue and bone sarcomas. Curr Oncol Rep 2003;5:295-303.